Skip to main content
Clinical Trials/NCT04063046
NCT04063046
Unknown
N/A

Effect of Anesthesia Technique on Early Outcome in Diabetic Patients Undergoing Lower Extremity Amputation

Yonsei University1 site in 1 country158 target enrollmentNovember 12, 2019

Overview

Phase
N/A
Intervention
General anesthesia
Conditions
Diabetic Foot
Sponsor
Yonsei University
Enrollment
158
Locations
1
Primary Endpoint
early prognosis (DVT Requiring Treatment)
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study was to compare

  1. early prognosis (mortality, morbidity)
  2. changes in concentrations of serum syndecan-1,partial pressure of oxygen(on arterial blood gas analysis), perioperative transfusion, intraoperative vasopressor use between general anesthesia and nerve block in diabetic patients undergoing limb amputation surgery as a prospective randomized trial.
Registry
clinicaltrials.gov
Start Date
November 12, 2019
End Date
September 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing diabetic foot limb amputation.
  • Patients aged 20 or older and who meet American Society of Anesthesiologists (ASA) physical class 3-4

Exclusion Criteria

  • patients with dementia or cognitive impairment
  • Patients who had previously undergone diabetic foot limb amputation within 1 month.
  • If the subject includes a person who can not read the written consent (eg, illiterate, foreigner, etc.)
  • pregnant or lactating women
  • Contraindications to nerve block (infection of the injection site, no cooperation, patient rejection, history of allergy ro local anesthetics)
  • Relative contraindications to general anesthesia (if difficult airways are expected, history of malignant hyperthermia, moderate or severe asthma)

Arms & Interventions

General anesthesia

General anesthesia involving intubation or supraglottic airway device insertion

Intervention: General anesthesia

peripheral nerve block

popliteal sciatic nerve block

Intervention: Peripheral nerve block

Outcomes

Primary Outcomes

early prognosis (DVT Requiring Treatment)

Time Frame: 30days after surgery

Indicate whether the patient has experienced a deep venous thrombosis (DVT) confirmed by doppler study, contrast study, or other study that required treatment.

early prognosis (Surgical Site Infection)

Time Frame: 30days after surgery

Indicate the extent of surgical site infection if one was present within 30 days of surgery.

early prognosis (New Central Neurological Event)

Time Frame: 30days after surgery

Indicate whether the patient experienced any of the following neurological events in the postoperative period that was not present preoperatively: 1. A central neurologic deficit persisting postoperatively for \> 72 hours. 2. A postoperatively transient neurologic deficit (TIA recovery within 24 hours; RIND recovery within 72 hours). 3. New postoperative coma that persists for at least 24 hours secondary to anoxic/ischemic and/or metabolic encephalopathy, thromboembolic event or cerebral bleed.

early prognosis (Renal failure)

Time Frame: 30days after surgery

Indicate whether the patient had acute renal failure or worsening renal function resulting in ONE OR BOTH of the following: 1. Increase in serum creatinine level 3.0 x greater than baseline, or serum creatinine level \>=4 mg/dL. Acute rise must be at least 0.5 mg/dl 2. A new requirement for dialysis postoperatively.

early prognosis (Pneumonia)

Time Frame: 30days after surgery

Indicate if the patient experienced pneumonia in the postoperative period. Pneumonia is defined as meeting three of five characteristics: fever, leucocytosis, CXR with infiltrate, positive culture from sputum, or treatment with antibiotics.

early prognosis (Myocardial Infarct)

Time Frame: 30days after surgery

Indicate if the patient experienced a MI postoperatively as evidenced by: 1. Transmural infarction: Defined by the appearance of a new Q wave in two or more contiguous leads on ECG, or 2. Subendocardial infarction: (non-Q wave) Infarction, which is considered present in a patient having clinical, angiographic, electrocardiographic, and/or 3. Laboratory biomarker (CPK,Troponin) evidence of myocardial necrosis with an ECG showing no new Q waves

early prognosis (mortality)

Time Frame: 30days after surgery

death within 30days after surgery

early prognosis (Respiratory failure)

Time Frame: 30days after surgery

Indicate whether the patient experienced respiratory failure in the postoperative period requiring mechanical ventilation and/or reintubation.

early prognosis (Delirium)

Time Frame: 30days after surgery

Indicate whether the patient experienced delirium in the postoperative period marked by illusions, confusion, cerebral excitement, and having a comparatively short course.

early prognosis (Unexpected return To The Operation Room)

Time Frame: 30days after surgery

Indicate whether the patient was unexpectedly returned to the Operation Room during this hospital visit.

Secondary Outcomes

  • changes in partial pressure of oxygen by arterial blood gas analysis(1 hour after end of operation)
  • changes in concentrations of serum syndecan-1(1 hour after end of operation)
  • perioperative transfusion(Postoperative 48hours)
  • intraoperative vasopressor use(Intraoperation)

Study Sites (1)

Loading locations...

Similar Trials